Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5630178 | Journal of Neuroimmunology | 2017 | 5 Pages |
â¢This is a study of the soluble membrane complex (sMAC) in CSF/plasma from 47 HIV-infected individuals as well as 11 HIV-negative individuals.â¢CSF sMAC was detectable at baseline in 22.7% of HIV + participants on cART compared to 0% of HIV-negative participants.â¢CSF sMAC levels correlated significantly with CSF HIV RNA levels.â¢Plasma sMAC levels declined significantly during antiretroviral therapy.â¢There was a negative association trend between sMAC and cognitive performance that warrants further investigation.
The soluble membrane attack complex (sMAC) represents the terminal product of the complement cascade. We enrolled 47 HIVÂ + adults (12 of whom underwent a second visit at least 24Â weeks after starting therapy) as well as 11 HIV negative controls. At baseline, cerebrospinal fluid (CSF) sMAC was detectable in 27.7% of HIVÂ + individuals. CSF sMAC correlated with CSF HIV RNA levels and was more likely to be detectable in HIVÂ + individuals on cART compared to HIV negative controls. In HIVÂ + participants, there were negative association trends between sMAC and neurocognitive performance but these did not reach statistical significance.
Graphical abstractDownload high-res image (87KB)Download full-size image